NDC 70518-2323-05 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-2323
- Requested NDC
- 70518-2323-05
- Package NDCs from labels
- 70518-2323-0, 70518-2323-1, 70518-2323-2, 70518-2323-3, 70518-2323-5, 70518-2323-4, 70518-2323-05
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2323-0 | Gabapentin | 30 in 1 BLISTER PACK | TABLET, FILM COATED | 30 | 14 | |
| 70518-2323-1 | Gabapentin | 90 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 90 | 14 | |
| 70518-2323-2 | Gabapentin | 180 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 180 | 14 | |
| 70518-2323-3 | Gabapentin | 120 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 120 | 14 | |
| 70518-2323-4 | Gabapentin | 100 in 1 BOX | TABLET, FILM COATED | 100 | 14 | |
| 70518-2323-5 | Gabapentin | 1 in 1 POUCH | TABLET, FILM COATED | 1 | 14 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2323 | GABAPENTIN TABLET, FILM COATED [REMEDYREPACK INC.] | 10 | Current NDC, Legacy NDC, 6 package rows | 20250312_429a1bb5-babf-4f36-8264-46d71164f1c0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70518-2323-1 | EA - Each | 70518-2323 | 61a3c50d-6021-430a-b8cf-e41ad9655ed5 | 1 | 2025-05-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 3dac0d5f-6e65-4c58-9d2a-4f6910b2d4ef | 2026-10-08 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | 915cee37-536c-4761-bdb9-b96c7ee0f956 | 2026-10-08 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Redpharm Drug | 58474aa7-7c6a-3a94-e063-6394a90a870b | 2026-10-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | 57492b91-1fe2-74ab-e063-6394a90a0b9e | 2026-10-02 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 09736975-2493-4dbc-bbe0-cc56a1fec53f | 2026-09-28 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | ScieGen Pharmaceuticals, Inc. | 16542ee6-0e0e-4d3c-8b32-60ff6ef48846 | 2026-09-25 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Asclemed USA, Inc. | 1f1203f4-2184-4e13-e063-6394a90a4330 | 2026-09-23 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | PD-Rx Pharmaceuticals, Inc. | 330ddc5d-c67c-33dc-e054-00144ff88e88 | 2026-09-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 49d314cb-90c5-4351-aa42-5838d5f7db28 | 2026-09-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 3e633cd0-5ee8-4a05-bcfc-0a80209bf27f | 2026-09-22 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 896c7782-1137-454b-aaa6-28f42c7413ef | 2026-09-21 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Major Pharmaceuticals | 36f74fdf-0dae-47a0-a7ea-e64ac91cd88f | 2026-09-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 429a1bb5-babf-4f36-8264-46d71164f1c0 | 2026-09-16 | Warnings, Adverse reactions | ANDA200651 70518-2323-3 70518-2323-2 70518-2323-1 70518-2323-4 70518-2323-0 70518-2323-5 70518-2323 70518232305 310434 5b98aeb1-2f0b-f869-e063-6394a90ab78e 429a1bb5-babf-4f36-8264-46d71164f1c0 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | REMEDYREPACK INC. | fbeccab7-08aa-4da3-868f-b47a1f3d41ef | 2026-09-14 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 1ec2e07e-5a8e-41e5-9ece-485431c7c4ee | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| gabapentin | GABAPENTIN | REMEDYREPACK INC. | 4a975ebe-ae0a-446a-8a3d-2ca325e28f93 | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Advanced Rx of Tennessee, LLC | 5b3ba5e9-6e96-dea6-e063-6394a90aa2bb | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 934244c6-243d-436e-ad6c-f7bd28e45a86 | 2026-09-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Clinical Solutions Wholesale, LLC | b7f9a106-52c6-49e4-acf5-8fb07761ba4f | 2026-09-09 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals,Inc. | d35cd5ac-5ed6-2405-e053-2995a90a6946 | 2026-09-03 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.